JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2007; 49:1306-1314, doi:10.1016/j.jacc.2006.11.033 (Published online 8 March 2007).
© 2007 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2006.11.033v1
49/12/1306    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takahashi, Y.
Right arrow Articles by Haïssaguerre, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takahashi, Y.
Right arrow Articles by Haïssaguerre, M.

CLINICAL RESEARCH: HEART RHYTHM DISORDER

Effects of Stepwise Ablation of Chronic Atrial Fibrillation on Atrial Electrical and Mechanical Properties

Yoshihide Takahashi, MD*, Mark D. O’Neill, MB, BCh, DPhil1, Méléze Hocini, MD7, Patricia Reant, MD, Anders Jonsson, MD2, Pierre Jaïs, MD6, Prashanthan Sanders, MBBS, PhD5,6, Thomas Rostock, MD3, Martin Rotter, MD4,7, Frédéric Sacher, MD, Stephane Laffite, MD, PhD, Raymond Roudaut, MD, Jacques Clémenty, MD and Michel Haïssaguerre, MD6

Hôpital Cardiologique du Haut-Lévêque, Université Victor Segalen Bordeaux 2, Bordeaux, France.

Manuscript received September 11, 2006; revised manuscript received October 30, 2006, accepted November 19, 2006.

* Reprint requests and correspondence: Dr. Yoshihide Takahashi, Service de Rythmologie, Hôpital Cardiologique du Haut-Lévêque, Avenue de Magellan, 33604 Bordeaux-Pessac, France. (Email: yoshihide_takahashi{at}oboe.ocn.ne.jp).


    Abstract
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
Objectives: This study sought to evaluate the effects of stepwise catheter ablation of chronic atrial fibrillation (AF) on atrial electrical and mechanical properties.

Background: Although stepwise catheter ablation of chronic AF is associated with acute arrhythmia termination and a favorable clinical outcome, atrial tissue damage following the procedure has not been evaluated.

Methods: Forty patients who had previously undergone catheter ablation of chronic AF were studied. In the index procedure, termination of AF was achieved by catheter ablation alone in 36 of 40 patients (90%). Electroanatomical mapping was performed in sinus rhythm ≥1 month after the index procedure, during which the surface area of scar (bipolar voltage of <0.05 mV), low-voltage tissue (<0.5 mV), and atrial propagation were evaluated. Left atrial (LA) mechanical function was assessed by transthoracic echocardiography.

Results: Electroanatomical mapping showed areas of scar and low-voltage accounting for 31% ± 12% and 32% ± 17% of the total LA surface area respectively, with the ablated pulmonary vein region accounting for 20% ± 4% of the LA surface area. The area of scar outside the pulmonary vein region represented 14% ± 12% of the LA surface area using the initial randomized ablation strategy, and 6% ± 8% (p = 0.02) using a specific ablation strategy. Atrial conduction was diversely affected by ablation with a wide range of LA conduction times observed (range 100 to 360 ms). The LA contraction was shown in all patients by the presence of late diastolic mitral flow (37 ± 15 cm/s) and a mean LA active emptying fraction of 18 ± 11%. At 9 ± 5 months of follow-up, 39 patients (98%) were in sinus rhythm.

Conclusions: Stepwise ablation achieving sinus rhythm in patients with chronic AF has a significant impact on LA electrical activity but is associated with recovery of LA function.

Abbreviations and Acronyms
  AF = atrial fibrillation
  AT = atrial tachycardia
  CS = coronary sinus
  LA = left atrium
  LAA = left atrial appendage
  LV = left ventricle
  PV = pulmonary vein
  RA = right atrium
  SVC = superior vena cava


Catheter ablation of atrial fibrillation (AF) can eliminate atrial arrhythmias leading to improvements in left atrial (LA) and left ventricular (LV) function and also quality of life (1–4). Various ablation techniques to modify atrial substrates in addition to pulmonary vein (PV) isolation have been proposed for treatment of long-lasting AF (5–7). A stepwise ablation approach combining multiple atrial and venous targets is capable of restoring sinus rhythm in chronic AF without pharmacological or electrical cardioversion and is associated with a favorable clinical outcome (8). However, this technique may damage extensive areas of the atrial myocardium, potentially resulting in loss of LA mechanical function and alteration of interatrial/intra-atrial conduction (7,8), in contrast to conventional ablation strategies deploying a stereotypic lesion set at specific anatomical structures (5,6,9–11).

The goal of the present study was to evaluate the impact of an extensive ablation strategy for chronic AF on the surface area of scar/low-voltage tissue, atrial propagation during sinus rhythm, and overall LA mechanical function.


    Methods
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
Study population.   The study was composed of 40 of 120 consecutive patients (33%) with symptomatic and drug-refractory chronic AF who had undergone previous catheter ablation. Electroanatomical mapping was performed during sinus rhythm ≥1 month after the index procedure (5 ± 3 months). In 29 patients, electroanatomical mapping was performed during a repeat ablation procedure for recurrent arrhythmias (paroxysmal AF/atrial tachycardia [AT] 8, persistent AF 0, persistent AT 21). The remaining 11 patients presented with symptomatic atrial ectopic beats and underwent an electrophysiological study. Baseline characteristics of the studied patients are presented in Table 1. All patients gave written informed consent to the study protocol, which was approved by our institutional review board.


View this table:
[in this window]
[in a new window]

 
Table 1 Baseline Characteristics of Patients (n = 40)
 
Catheter ablation.   The index procedural end point was restoration of sinus rhythm without antiarrhythmic drugs or electrical cardioversion. If AF was converted into AT, mapping and catheter ablation of subsequent AT was performed. The AT was defined as an organized atrial rhythm with a monomorphic P-wave and consistent endocardial activation sequence in both atria.

The techniques of catheter ablation performed in the index procedure have been presented elsewhere (8). In brief, ablation was performed using a 3.5-mm irrigated-tip ablation catheter (Biosense-Webster, Diamond Bar, California) at the following sites. (i) The PV isolation was performed with the end point of the abolition or dissociation of activities in all PVs. (ii) The superior vena cava (SVC) was isolated using the same technique and end point as used for PV isolation. If AF was terminated before targeting the SVC, the SVC was not ablated. (iii) The coronary sinus (CS) region was targeted first from the LA endocardium bordering the mitral annulus (inferior LA along the CS) and within the vessel if local rapid activities persisted. The end point was significant slowing of CS activity. (iv) Atrial ablation was performed at all sites showing any of the following electrogram features: continuous electrical activity, complex and fractionated electrograms, a gradient of activation (a temporal gradient of at least 70 ms between the distal and proximal bipoles on the map electrode, potentially representing a local circuit), or shorter cycle length activity compared with the left atrial appendage (LAA). The end points of atrial ablation were conversion of continuous or fractionated electrograms to discrete electrograms, loss of activation gradient (organization of activity), or prolongation of local cycle length until similar to or greater than that recorded in the LAA. (v) Linear ablation was performed at the cavotricuspid isthmus, the LA roof, and the mitral isthmus. The end point of linear ablation during AF was significant reduction or abolition of local electrograms. After restoration of sinus rhythm, additional ablation was performed until completion of conduction block as described elsewhere (5,6). In patients with persistent AF after steps (i) to (v) inclusive, ablation was performed in the right atrium (RA) in the same manner as used in step (iv).

In the initial 70 consecutive patients, PV isolation, SVC disconnection, CS ablation, and atrial ablation in the LA were performed in a randomized sequence followed by linear ablation and atrial ablation in the RA until AF was terminated (randomized ablation strategy). Based on the results of a previous study (8), ablation was performed in a specific sequence in the last 50 consecutive patients as follows: PV isolation and roof line ablation were performed first, followed by CS and atrial ablation (specific ablation strategy). The SVC disconnection was performed optionally if the local cycle length was shorter than elsewhere in the RA.

Twenty-five and 15 patients underwent the randomized and specific ablation strategies, respectively. Termination of AF was defined as restoration of sinus rhythm or conversion into AT, and was achieved by catheter ablation alone in 36 of 40 patients (90%).

Electrophysiological study.   All patients received antiarrhythmic drugs for 2 months after the index procedure, and discontinued these drugs ≥5 half-lives before the study. Amiodarone was being taken by 11 patients (28%) at the time of the study.

The surface electrocardiogram and intracardiac electrograms were measured at a sweep speed of 100 mm/s using a digital amplifier/recording system (Bard Electrophysiology, Lowell, Massachusetts). A single bolus of 50 IU/kg of heparin was administered after the transseptal puncture. For endocardial mapping, a 6-F quadripolar catheter (Xtrem, ELA Medical, Montrouge, France) was positioned in the CS. Electroanatomical mapping of the LA and/or RA using the Carto system (Biosense-Webster) was performed during either sinus rhythm (LA 36, RA 24) or pacing at a cycle length of 600 ms from the CS, LAA, or RA appendage (LA 4, RA 2) when ectopic beats were present.

The earliest activation site in the sinus node region was distinguished as multicentric or unicentric pacemaker activity. Multicentric pacemaker activity was defined as the presence of earliest activation sites separated by ≥10 mm with an activation time difference of ≤5 ms (12). Unicentric pacemaker activity was defined as the presence of localized earliest activation site surrounded by sites with an activation time difference of >5 ms.

Interatrial and intra-atrial conduction times were evaluated by duration from onset of P-wave to earliest and latest activation time in the LA.

Electrically silent areas (scar) were defined as those with absence of recordable activity or a bipolar voltage amplitude <0.05 mV; low-voltage areas were defined as those with contiguous areas <0.5 mV on bipolar voltage maps, as reported elsewhere (12,13). Mean bipolar voltage of the chamber was calculated from all acquired points including those displaying electrical silence. Higher-density mapping was performed to evaluate scar/low-voltage areas; the location of scar/low-voltage tissue was described and the percentage of LA surface area occupied by this tissue was determined. For the purpose of analysis, the LA was divided into 8 regions: the PV, LAA, anterior LA, LA roof, septal LA, posterior LA, inferior LA, and lateral LA. Atrial tissue 0.5 to 1.0 cm from the PV ostia was included within the PV region. The posterior LA approximated a square, the corners of which were defined by the 4 PV orifices. The LA roof was defined as a band of 1 to 2 cm between the superior PVs, which separated the posterior LA from the anterior LA. The anterior LA extended from the LA roof to the superior mitral annulus. The inferior LA extended from the lower aspect of the 2 inferior PV ostia to the inferior mitral annulus. The lateral LA was defined as atrial tissue between the posterolateral mitral annulus (4 o’clock) and the lower lip of the LAA.

Follow-up and echocardiograms.   Patients were hospitalized for 1 day at 1, 3, 6, and 12 months after the procedure for clinical review and ambulatory monitoring. Antiarrhythmic drugs were administered for 2 months after the index procedure. If tachyarrhythmia was not observed during this period, these antiarrhythmic drugs were discontinued.

Transthoracic echocardiography was performed ≥1 month after the electroanatomical mapping, by which time persistent recurrent arrhythmias were eliminated and stable sinus rhythm was restored. Pulsed Doppler gains were adjusted to provide a smooth velocity distribution without introducing noise at a 100-mm/s sweep speed. All measures were acquired in sinus rhythm and stored on magnetic optical disks for offline analysis with a customized software package (Echopac, GE Medical Systems, Horten, Norway). The LA volumes at P-wave onset and end-systolic volume were calculated using the electrocardiogram as a timing reference. The LA active emptying volume and LA active emptying fraction were then derived. Late diastolic peak velocity (peak A-wave velocity) was measured from the apical 4-chamber view in patients in whom sinus rhythm was maintained, with the sample volume placed at the tip of the mitral leaflets by averaging 3 consecutive cycles. The LA filling fraction was also calculated from time velocity integral of mitral flow (3). Reproducibility of the aforementioned measurements has been reported elsewhere (3).

Statistical analysis.   Continuous variables are expressed as mean ± SD. A comparison between the groups was performed with the Student t test or the Wilcoxon rank-sum test, as appropriate. A paired comparison was performed using the Student t test or the Wilcoxon signed rank test, as appropriate. All tests of significance were 2-tailed, and a p value <0.05 was considered as statistically significant.


    Results
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
Electroanatomical mapping.   Electroanatomical maps of the LA and RA were created with 81 ± 15 and 73 ± 20 points, respectively. High-density mapping was performed at the borders between scar and low-voltage tissue, or low-voltage tissue and tissue with a voltage of ≥0.5 mV, thus 53% of points in the LA were acquired in low-voltage tissue. The volumes of the LA and RA geometries created by Carto were 89 ± 37 cm3 and 95 ± 25 cm3, respectively, and their surface areas were 115 ± 26 cm2 and 129 ± 22 cm2, respectively.

Atrial propagation during sinus rhythm.   The median atrial cycle length was 930 ms (range 600 to 1,350 ms) during mapping in the RA. All but 1 patient showed the earliest activity in the posterior RA along the crista terminalis, and 1 patient showed the earliest activity in the high anterolateral RA. Unicentric pacemaker activity was observed in 12 patients (50%) (Fig. 1), and caudal shift of the earliest activation (≥20 mm from the junction of the RA and SVC) was observed in 6 patients (25%).


Figure 1
View larger version (27K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 Electroanatomical Mapping of the Right Atrium Displaying Activation Time and Bipolar Voltages

(A) Unicentric pacemaker activity is observed in the midposterior right atrium 28 mm from the junction of the superior vena cava. (B) Purple represents bipolar voltages of ≥0.5 mV.

 
Earliest activation in the LA was observed 36 ± 18 ms after the onset of the P-wave at the high anterior LA in 24 patients (67%), corresponding to the insertion site of Bachmann bundle into the LA (Fig. 2). Three patients showed simultaneous activation in the Bachmann bundle insertion region and LA septum. In the remaining 12 patients, the site of earliest activation was the LA septum; in 11 of these 12 patients, the Bachmann bundle insertion region showed low-voltage or scar (Fig. 3).


Figure 2
View larger version (63K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2 Propagation Map of the Left and Right Atrium During Sinus Rhythm

Earliest activation is the high anterior left atrium, corresponding to the Bachmann bundle insertion (A to D).

 

Figure 3
View larger version (38K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3 Activation Map and Bipolar Voltage Map of the LA During Sinus Rhythm in a Patient Who Underwent the Randomized Ablation Strategy

(A) Earliest activation is 30 ms after P-wave onset in the septum (red). Latest activation is after QRS complex in the left atrial (LA) appendage (dark blue), at 325 ms after P-wave onset. (B) Scar or low-voltage area is observed in the anterior LA and septum. Tissue damage in these regions seems to be associated with intra-atrial conduction abnormality. Purple represents bipolar voltages of ≥0.5 mV.

 
During sinus rhythm, the site of latest activation in the LA occurred at 181 ± 65 ms (range 100 to 360 ms) after the onset of the P-wave: at the LAA (16 patients, 44%), posterior LA (10 patients, 28%), or lateral LA (10 patients, 28%). In 4 patients (11%), the latest activity in the LA occurred after the QRS complex (LAA 3 and posterior LA 1) (Fig. 3). In 78%, 11%, and 11% of patients, atrial activation was complete before QRS, during QRS, and after QRS, respectively.

In the LA, the earliest and latest activations occurred at similar times after the onset of the P-wave irrespective of amiodarone use (p = 0.79, p = 0.38, respectively).

Voltage map.   Mean bipolar voltages in the LA and RA were 0.60 ± 0.33 mV and 1.60 ± 0.69 mV (p < 0.0001), respectively (Fig. 4). Voltages in the LA and RA were similar between patients who were taking and not taking amiodarone at the time of the study (p = 0.5, p = 0.35, respectively). All electroanatomical maps showed bipolar electrograms with voltages of >0.5 mV in the LAA (Figs. 3 to 6).GoGo


Figure 4
View larger version (33K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 4 Bipolar Voltage Map of Both Atria in an Anteroposterior Projection and a Posteroanterior Projection in a Patient Who Underwent Randomized Ablation Strategy

In the right atrium, there is no scar and 8% of low-voltage area. In contrast, scar is present around the pulmonary veins at the posterior and inferior left atrium, accounting for 44% of the left atrium surface area and low-voltage area is present at the roof, anterior left atrium, septum, and inferior left atrium, accounting for 39% of the left atrium surface area (A and B). Note that bipolar voltages in the left atrial appendage are ≥0.5 mV. This patient showed late diastolic mitral flow of 30 cm/s at 3 months after catheter ablation.

 

Figure 5
View larger version (29K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 5 Bipolar Voltage Map of the LA in a Patient Who Underwent the Specific Ablation Strategy

(A) Anteroposterior projection; (B) posteroanterior projection. Scar tissue is limited in the pulmonary vein region, accounting for 17% of the left atrial (LA) surface areas. Low-voltage tissue is present in the anterior LA and LA roof, accounting for 5% of the LA surface areas. Purple represents bipolar voltages of ≥0.5 mV.

 

Figure 6
View larger version (26K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 6 Incidence of Low-Voltage and Scar Tissue in the Left Atrium

LAA = left atrial appendage.

 
The percentages of surface area accounted for by scar in the LA and RA were 31 ± 12% and 0 ± 1% (p < 0.0001), respectively, and the percentages of surface area of low-voltage tissue in the LA and RA were 32 ± 17% and 7 ± 10% (p < 0.0001), respectively. In all patients, the ablated PV region was accounted for by scar, representing 20 ± 4% of the total surface area of the LA (i.e., two-thirds of the total LA scar). Scar area outside the PV was 11 ± 11% (range 0% to 45%) of the LA surface area. The distribution of scar and low-voltage tissue in each region of the LA is shown in Figure 6.

Voltages in the Bachmann bundle region and atrial conduction.   Twenty-one patients (58%) had low-voltage electrograms or scar in the anterior LA, that is, the Bachmann bundle insertion region. Although these patients had similar early onset of LA activation as the others (from P-wave onset: 37 ± 19 ms [range 14 to 83 ms] vs. 35 ± 17 ms [range 14 to 70 ms], p = 0.83), the time to completion of activation in the LA was significantly prolonged (from P-wave onset: 203 ± 64 ms [range 126 to 360 ms] vs. 152 ± 57 ms [range 100 to 330 ms], p < 0.003) (Fig. 3).

Surface area of scar/low-voltage tissue and ablation strategy.   The percentages of surface area of scar and low-voltage tissue in the LA were compared between patients who underwent the randomized ablation strategy and specific ablation strategy (Figs. 3 to 5, Table 2). The percentages of surface area of low-voltage tissue were similar for both strategies (32 ± 17% vs. 31 ± 19%, p = 0.87), whereas that of scar was lower (26 ± 9% vs. 34 ± 13%, p = 0.066) in patients undergoing the specific ablation strategy. This difference was related to scar areas outside the PV region (6 ± 8% [range 0% to 28%] vs. 14 ± 12% [range 0% to 45%], p = 0.02) as a consequence of significantly shorter radiofrequency durations in the specific ablation strategy group (81 ± 22 min vs. 99 ± 22 min, p = 0.01).


View this table:
[in this window]
[in a new window]

 
Table 2 Variables of Patients Who Underwent Randomized Ablation Strategy and Specific Ablation Strategy
 
Follow-up.   Six patients (15%) underwent a repeat procedure for clinically recurrent arrhythmias at a median of 7 months (range 2 to 10 months) after the electroanatomical mapping. Mapping showed conduction recovery in 4 patients (right inferior PV 1, roof line 2, and mitral isthmus line 1) and a focal source in 2 patients (CS and RA). At 9 ± 5 months of follow-up from the index procedure, 39 patients (98%) were in sinus rhythm (35 patients [88%] were without antiarrhythmic drugs), of whom 1 patient had paroxysmal atrial arrhythmia. A single patient had persistent AT, and is awaiting a repeat procedure (Fig. 7).


Figure 7
View larger version (21K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 7 Clinical Outcome of the Studied Patients

AF = atrial fibrillation; AT = atrial tachycardia; pt = patient.

 
Echocardiograms.   Transthoracic echocardiograms were performed during stable sinus rhythm at a mean of 4 ± 3 months after the electroanatomical mapping. Compared with echocardiography performed before the index procedure (baseline), LV end-diastolic and end-systolic diameters decreased and LV ejection fraction increased without reaching statistical significance (55 ± 8 mm vs. 53 ± 5 mm, p = 0.11; 37 ± 11 mm vs. 34 ± 6 mm, p = 0.2; 58 ± 16% vs. 62 ± 10%, p = 0.2). The LA diameters decreased significantly (parasternal: 46 ± 8 mm vs. 41 ± 8 mm, p = 0.002; longitudinal: 59 ± 9 mm vs. 54 ± 10 mm, p = 0.001; transverse: 46 ± 8 mm vs. 41 ± 8 mm, p = 0.03). In 11 patients (28%) with a baseline LV ejection fraction ≤45%, LV ejection fraction significantly increased from baseline (median 43% [range 15% to 45%] vs. median 62% [range 38% to 68%], p = 0.02). The LV and LA dimensions after electroanatomical mapping were similar in patients irrespective of ablation strategy (LV end-diastolic diameter p = 0.8, LV end-systolic diameter p = 1.0, LA parasternal diameter p = 0.9, LA longitudinal diameter p = 0.8, LA transverse diameter p = 0.6).

All patients showed the presence of active late diastolic mitral flow with a mean peak velocity of 37 ± 15 cm/s (Fig. 8). The LA active emptying volume and the LA active emptying and filling fraction was available in 22 patients and were 8.3 ± 10.3 ml/m2, 18 ± 11%, and 15 ± 9%, respectively. These variables were similar for both ablation strategies (Table 2).


Figure 8
View larger version (123K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 8 Doppler Tracing at the Mitral Valve Inflow

Late diastolic mitral flow is shown.

 

    Discussion
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
The present study describes the electrical and mechanical consequences of stepwise ablation of chronic AF. First, it quantifies the extent of scar or low-voltage areas after the procedure. Second, it shows the recovery of LA contractile function in the 98% of patients in whom sinus rhythm was maintained.

Evaluation of scar and low-voltage areas.   Pulmonary vein isolation accounted for two-thirds of the total LA scar burden after ablation. Ablation in all other atrial regions aiming to achieve local organization and slowing of fibrillation cycle length was associated with a relative preservation of atrial voltages and propagation.

Although the presence of spontaneous scar in patients with AF is known (13), the extent of pre-existing scar or low-voltage areas was not investigated in the present study. Atrial bipolar voltage mapping after an ablation procedure estimates the viability of atrial tissue (14,15), but cannot distinguish between spontaneous and iatrogenic scar/low-voltage tissue. The extent of tissue damaged by ablation therefore may be smaller than that measured as scar or low-voltage tissue in the present study. From a clinical perspective, the distinction between spontaneous and iatrogenic scar is unlikely to be relevant, however, because both are likely to have similar electrical and mechanical consequences for atrial function.

Currently, many investigators target the posterior LA in addition to the PV and mitral isthmus linear lesion in surgical or ablative procedures for AF (2,16,17). The ablated areas using this approach account for 30% to 40% of the LA surface area (11). In the present study, the surface area of scar is comparable, but the distribution of lesions outside the PV is different. In one-third of patients undergoing stepwise ablation, an absence of scar or low-voltage tissue was shown in the posterior LA (Fig. 6). Instead, reduction of bipolar voltages was observed in the other regions such as the anterior LA or inferior LA, which are important regions in perpetuation of AF and thus may be targeted provided that AF termination is the desired procedural end point (7,8).

LA contraction.   Recovery of atrial mechanical function is a major goal in the treatment of AF. Extensive catheter ablation of atrial tissue replaces myocardium with scar and prolongs intra-atrial conduction, thereby potentially compromising atrial mechanical performance. This is supported by the loss of LA contraction in 13% to 39% of patients who underwent the maze procedure despite remaining in sinus rhythm (18–21). This is in marked contrast to the present study, in which all patients in whom sinus rhythm was maintained after ablation showed recovery of LA contraction.

In the surgical treatment of AF, preservation of the LAA improves atrial contraction compared with the maze procedure in which the LAA is removed (22). Isobe et al. (20) showed that all patients had the presence of LA contraction after the surgical procedure in which both atrial appendages were preserved, whereas 27.5% of patients showed loss of LA contraction after the maze III procedure in which both appendages are removed. The ablation strategy in the present study avoids electrical disconnection of the LAA, and the resultant preserved bipolar voltages within the LAA may contribute to the restoration of LA contraction after ablation in a fashion analogous to LAA preservation during surgery.

A prior report has shown that preoperative LV ejection fraction and LA diameter are predictors of the presence of atrial contraction after the maze procedure (19), suggesting that an underlying atrial pathology is one factor associated with LA contraction. Although patients with a low ejection fraction or LA dilatation were included in the present study, recovery of LA contraction was observed in all patients in sinus rhythm.

Few data are available about echocardiographic evaluation of LA mechanical function after catheter ablation of chronic AF. A previous report in which PV isolation and linear lesions (roof line and mitral isthmus line) were performed showed that LA active emptying volume and emptying fraction (4.7 ± 2.14 ml/m2, 21.8 ± 11%, respectively) were comparable with those in the present study (3), despite the fact that less atrial tissue was targeted.

Although recovery of LA contraction was shown in all patients in whom sinus rhythm was maintained after stepwise ablation, extensive atrial scar may be associated with suboptimal LA mechanical function, and the long-term effects on LA contraction and endothelial function are unknown. It is likely that the smaller the surface area occupied by scar tissue, the greater the likely benefit for atrial contractile function.

The presence of scar/low-voltage tissue in the LA, especially in the Bachmann bundle insertion, was associated with prolongation of LA conduction times. Intra-LA conduction disturbance results in asynchronized contraction of the LA, possibly attenuating atrial contractile performances. Furthermore, in patients in whom the latest activity in the LA occurred after the QRS, LA contribution to LV filling is smaller because of closure of the mitral valve before completion of LA contraction. Further refinement of techniques to identify sites crucial for maintenance of AF or subsequent AT on an individual basis is therefore necessary to minimize the extent of LA injury and to maximize the mechanical benefit of catheter ablation therapy for AF.

Conclusions.   Stepwise ablation of chronic AF is associated with maintenance of sinus rhythm and recovery of LA function despite significant scarring in the LA.


    Footnotes
 
1 Dr. O’Neill is supported by a British Heart Foundation International Fellowship. Back

2 Dr. Jonsson is supported by the Swedish Society of Cardiology. Back

3 Dr. Rostock is supported by the German Cardiac Society. Back

4 Dr. Rotter is supported by the Swiss National Foundation for Scientific Research, Bern, Switzerland. Back

5 Dr. Sanders is supported by the Neil Hamilton Fairley Fellowship from the National Health and Medical Research Council of Australia and the Ralph Reader Fellowship from the National Heart Foundation of Australia. Back

6 Drs. Jaïs, Sanders, and Haïssaguerre have served on the advisory boards of and have received lecture fees from Biosense-Webster and Bard Electrophysiology. Back

7 Drs. Hocini and Rotter have received lecture fees from Biosense-Webster. Back


    References
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 

  1. Hsu LF, Jais P, Sanders P, et al. Catheter ablation for atrial fibrillation in congestive heart failure N Engl J Med 2004;351:2373-2383.[Abstract/Free Full Text]
  2. Oral H, Pappone C, Chugh A, et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation N Engl J Med 2006;354:934-941.[Abstract/Free Full Text]
  3. Reant P, Lafitte S, Jais P, et al. Reverse remodeling of the left cardiac chambers after catheter ablation after 1 year in a series of patients with isolated atrial fibrillation Circulation 2005;112:2896-2903.[Abstract/Free Full Text]
  4. Verma A, Kilicaslan F, Adams JR, et al. Extensive ablation during pulmonary vein antrum isolation has no adverse impact on left atrial function: an echocardiography and cine computed tomography analysis J Cardiovasc Electrophysiol 2006;17:741-746.[CrossRef][ISI][Medline]
  5. Jais P, Hocini M, Hsu LF, et al. Technique and results of linear ablation at the mitral isthmus Circulation 2004;110:2996-3002.[Abstract/Free Full Text]
  6. Hocini M, Jais P, Sanders P, et al. Techniques, evaluation, and consequences of linear block at the left atrial roof in paroxysmal atrial fibrillation: a prospective randomized study Circulation 2005;112:3688-3696.[Abstract/Free Full Text]
  7. Nademanee K, McKenzie J, Kosar E, et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate J Am Coll Cardiol 2004;43:2044-2053.[Abstract/Free Full Text]
  8. Haissaguerre M, Sanders P, Hocini M, et al. Catheter ablation of long-lasting persistent atrial fibrillation: critical structures for termination J Cardiovasc Electrophysiol 2005;16:1125-1137.[CrossRef][ISI][Medline]
  9. Marrouche NF, Martin DO, Wazni O, et al. Phased-array intracardiac echocardiography monitoring during pulmonary vein isolation in patients with atrial fibrillation: impact on outcome and complications Circulation 2003;107:2710-2716.[Abstract/Free Full Text]
  10. Ouyang F, Bansch D, Ernst S, et al. Complete isolation of left atrium surrounding the pulmonary veins: new insights from the double-Lasso technique in paroxysmal atrial fibrillation Circulation 2004;110:2090-2096.[Abstract/Free Full Text]
  11. Pappone C, Manguso F, Vicedomini G, et al. Prevention of iatrogenic atrial tachycardia after ablation of atrial fibrillation: a prospective randomized study comparing circumferential pulmonary vein ablation with a modified approach Circulation 2004;110:3036-3042.[Abstract/Free Full Text]
  12. Sanders P, Morton JB, Kistler PM, et al. Electrophysiological and electroanatomic characterization of the atria in sinus node disease: evidence of diffuse atrial remodeling Circulation 2004;109:1514-1522.[Abstract/Free Full Text]
  13. Verma A, Wazni OM, Marrouche NF, et al. Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation: an independent predictor of procedural failure J Am Coll Cardiol 2005;45:285-292.[Abstract/Free Full Text]
  14. de Groot NM, Schalij MJ, Zeppenfeld K, Blom NA, Van der Velde ET, Van der Wall EE. Voltage and activation mapping: how the recording technique affects the outcome of catheter ablation procedures in patients with congenital heart disease Circulation 2003;108:2099-2106.[Abstract/Free Full Text]
  15. Kornowski R, Hong MK, Gepstein L, et al. Preliminary animal and clinical experiences using an electromechanical endocardial mapping procedure to distinguish infarcted from healthy myocardium Circulation 1998;98:1116-1124.[Abstract/Free Full Text]
  16. Todd DM, Skanes AC, Guiraudon G, et al. Role of the posterior left atrium and pulmonary veins in human lone atrial fibrillation: electrophysiological and pathological data from patients undergoing atrial fibrillation surgery Circulation 2003;108:3108-3114.[Abstract/Free Full Text]
  17. Gaita F, Gallotti R, Calo L, et al. Limited posterior left atrial cryoablation in patients with chronic atrial fibrillation undergoing valvular heart surgery J Am Coll Cardiol 2000;36:159-166.[Abstract/Free Full Text]
  18. Feinberg MS, Waggoner AD, Kater KM, Cox JL, Lindsay BD, Perez JE. Restoration of atrial function after the maze procedure for patients with atrial fibrillationAssessment by Doppler echocardiography. Circulation 1994;90:II285-II292.[Medline]
  19. Bauer EP, Szalay ZA, Brandt RR, et al. Predictors for atrial transport function after mini-maze operation Ann Thorac Surg 2001;72:1251-1254.[Abstract/Free Full Text]
  20. Isobe F, Kumano H, Ishikawa T, et al. A new procedure for chronic atrial fibrillation: bilateral appendage-preserving maze procedure Ann Thorac Surg 2001;72:1473-1478.[Abstract/Free Full Text]
  21. Yuda S, Nakatani S, Kosakai Y, Yamagishi M, Miyatake K. Long-term follow-up of atrial contraction after the maze procedure in patients with mitral valve disease J Am Coll Cardiol 2001;37:1622-1627.[Abstract/Free Full Text]
  22. Nitta T, Lee R, Watanabe H, et al. Radial approach: a new concept in surgical treatment for atrial fibrillationII. Electrophysiologic effects and atrial contribution to ventricular filling. Ann Thorac Surg 1999;67:36-50.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
Y. Takahashi, M. D. O'Neill, M. Hocini, R. Dubois, S. Matsuo, S. Knecht, S. Mahapatra, K.-T. Lim, P. Jais, A. Jonsson, et al.
Characterization of electrograms associated with termination of chronic atrial fibrillation by catheter ablation.
J. Am. Coll. Cardiol., March 11, 2008; 51(10): 1003 - 1010.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
L. Arrantes, F. Gaita, K.-t. Lim, M. Scaglione, P. Jais, M. Hocini, S. Matsuo, S. Knecht, and M. Haissaguerre
Atrial fibrillation ablation: evolution of the curative approach
Eur. Heart J. Suppl., December 1, 2007; 9(suppl_I): I129 - I135.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
D. G. Katritsis and A. J. Camm
Catheter ablation of atrial fibrillation: do we know what we are doing?
Europace, November 1, 2007; 9(11): 1002 - 1005.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2006.11.033v1
49/12/1306    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takahashi, Y.
Right arrow Articles by Haïssaguerre, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takahashi, Y.
Right arrow Articles by Haïssaguerre, M.


HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK